Cyp3a Inducers + Remibrutinib Interaction

Majorinteraction on record

Description

Concomitant use decreases remibrutinib exposure and may decrease efficacy. Avoid concomitant use.

Mechanism

Remibrutinib is a CYP3A4 substrate; induction decreases exposure

Source: NLP:remibrutinib